Literature DB >> 18373097

[Non-Hodgkin lymphoma of the lacrimal gland].

J Yayan1, A Mallouhi, P Moser, E Irschick.   

Abstract

BACKGROUND: Non-Hodgkin lymphoma is a systemic disease and various organs can therefore be affected. Ocular manifestations of non-Hodgkin lymphomas are possible but involvement of the eyelids or lacrimal glands are uncommon. CASE REPORT: A 63-year-old female patient suffered from a painless upper eyelid swelling of the left eye for 3 weeks. The anterior and posterior parts of the eyes showed no pathologic signs and X-ray examination of both orbits revealed no pathologic findings. Magnetic resonance imaging and computer tomography of the head revealed a neoplasm of the left lacrimal gland and also of the left parotid gland. The histologic examination revealed a recurrent non-Hodgkin lymphoma.
CONCLUSIONS: The causes of eyelid swellings can be multiple, however, painless swellings may also be caused by neoplasms. In the case described here it was interesting that behind a painless eyelid swelling even a systemic disorder was hidden, i.e. a recurrence of a non-Hodgkin lymphoma, which was localized in the lacrimal gland.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18373097     DOI: 10.1007/s00347-008-1698-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  13 in total

1.  Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options.

Authors:  Didier Decaudin; Patricia de Cremoux; Anne Vincent-Salomon; Remi Dendale; Livia Lumbroso-Le Rouic
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

2.  Expect the unexpected.

Authors:  I C Francis; G Wilcsek
Journal:  Br J Ophthalmol       Date:  2006-08       Impact factor: 4.638

3.  Monoclonal antibodies in the diagnosis of lymphoproliferative diseases of the orbit and orbital adnexae.

Authors:  A J Norton
Journal:  Eye (Lond)       Date:  2006-10       Impact factor: 3.775

4.  Lymphoma of the ocular adnexa: A study of 353 cases.

Authors:  Judith A Ferry; Claire Y Fung; Lawrence Zukerberg; Mark J Lucarelli; Robert P Hasserjian; Frederic I Preffer; Nancy L Harris
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

Review 5.  Lymphomas involving the eye and the ocular adnexa.

Authors:  Sarah E Coupland; Bertil Damato
Journal:  Curr Opin Ophthalmol       Date:  2006-12       Impact factor: 3.761

6.  Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases.

Authors:  S E Coupland; L Krause; H J Delecluse; I Anagnostopoulos; H D Foss; M Hummel; N Bornfeld; W R Lee; H Stein
Journal:  Ophthalmology       Date:  1998-08       Impact factor: 12.079

7.  [Intraocular non-Hodgkin's lymphoma and its therapy-- a case series of ten patients].

Authors:  K Siepmann; J M Rohrbach; G Duncker; M Zierhut
Journal:  Klin Monbl Augenheilkd       Date:  2004-04       Impact factor: 0.700

8.  A clinicopathologic evaluation of follicular lymphoma grade 3A versus grade 3B reveals no survival differences.

Authors:  Eric D Hsi; Imran Mirza; Gerard Lozanski; John Hill; Brad Pohlman; Matthew T Karafa; Robert Coupland
Journal:  Arch Pathol Lab Med       Date:  2004-08       Impact factor: 5.534

9.  Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas.

Authors:  Luigi Rigacci; Luca Nassi; Marco Puccioni; Silvia Mappa; Ennio Polito; Serena Dal Pozzo; Renato Alterini; Valentina Carrai; Benedetta Puccini; Alberto Bosi
Journal:  Ann Hematol       Date:  2007-05-05       Impact factor: 3.673

10.  Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa.

Authors:  Jae-Lyun Lee; Min-Kyoung Kim; Kyung Hee Lee; Myung Soo Hyun; Hwa Sun Chung; Dong Suk Kim; Sei One Shin; Hee Soon Cho; Sung Hwa Bae; Hun Mo Ryoo
Journal:  Ann Hematol       Date:  2004-08-10       Impact factor: 3.673

View more
  1 in total

1.  [Follicular conjunctivitis of unknown origin].

Authors:  S Goebels; A K Hasenfus; B K Kellner; U Löw; B Seitz
Journal:  Ophthalmologe       Date:  2012-01       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.